Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. Kim JJ, Simms KT, Killen J, Smith MA, et al. PLoS Med 2021;18:e1003534.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim JJ, Simms KT, Killen J, Smith MA, et al. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Med 2021;18:e1003534.
PMID: 33705382